Journal of Cancer Research and Therapeutics Close
 

Figure 3: (a) The phenotypic alterations of TE13, TE13 after TGF-β treatment, and TE13R120 cells were studied by inverted microscope. (b) The mRNA expression of E-cadherin and vimentin in TE13 cells group, TE13 after TGF-β treatment, and TE13R120 cells group. (c) The protein expression of E-cadherin and vimentin in TE13 cells group, TE13 after TGF-β treatment, and TE13R120 cells group

Figure 3: (a) The phenotypic alterations of TE13, TE13 after TGF-β treatment, and TE13R120 cells were studied by inverted microscope. (b) The mRNA expression of E-cadherin and vimentin in TE13 cells group, TE13 after TGF-β treatment, and TE13R120 cells group. (c) The protein expression of E-cadherin and vimentin in TE13 cells group, TE13 after TGF-β treatment, and TE13R120 cells group